Minimally invasive lumbar decompression: a review of indications, techniques, efficacy and safety

Author:

Jain Sameer1,Deer Timothy2,Sayed Dawood3,Chopra Pooja4,Wahezi Sayed5,Jassal Navdeep6,Weisbein Jackie7,Jameson Jessica8,Malinowski Mark9,Golovac Stanley10

Affiliation:

1. Pain Treatment Centers of America, Little Rock, AR 72211, USA

2. The Spine & Nerve Center of The Virginias, Charleston, WV 25301, USA

3. University of Kansas Hospital, Kansas City, KS 66160, USA

4. The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA

5. Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY 10461, USA

6. Spine & Pain Institute of Florida, Lakeland, FL 33805, USA

7. Napa Valley Orthopaedic Medical Group, Napa, CA 94558, USA

8. Axis Spine Center, Coeur d'Alene, ID 83815, USA

9. Adena Health System, Chillicothe, OH 45601, USA

10. Florida Pain Institute, Melbourne, FL 32940, USA

Abstract

Lumbar spinal stenosis is a common degenerative spine condition. In properly selected patients, minimally invasive lumbar decompression ( mild®) may be an option to improve outcomes. This review provides an in-depth description of the mild procedure and a comprehensive examination of safety and efficacy. Two randomized controlled trials, together with 11 other controlled clinical studies, have established the efficacy of mild, which is a minimally invasive procedure that does not involve implants and has demonstrated excellent efficacy and safety. With an established safety profile equivalent to epidural steroid injections, and efficacy that has been shown to be superior to such injections, mild can reasonably be positioned early in the treatment algorithm for these patients. Based on extensive review of the literature, robust safety and efficacy through 2 years, and in accordance with minimally invasive spine treatment guidelines, mild is recommended as the first intervention after failure of conservative measures for lumbar spinal stenosis patients with neurogenic claudication and ligamentum flavum hypertrophy.

Publisher

Future Medicine Ltd

Subject

General Medicine

Cited by 25 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3